SCHEMBL6599150

SCHEMBL6599150

Nn1cnc2cc[c]cc21

nearest known ligand 0.41

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6599368 0.84
SCHEMBL1537933 0.76 DYRK1A (0.40) TDP1
SCHEMBL16097951 0.73
SCHEMBL2386044 0.73 FGFR1 (0.33)
SCHEMBL1537974 0.72 TDP1 (0.39) TDP1
SCHEMBL7818042 0.72 HCAR3 (0.43)
SCHEMBL3663099 0.72 NPC1 (0.37)
SCHEMBL15987561 0.71 HTT (0.62)
SCHEMBL145442 0.70 TDP1 (0.54) TDP1
SCHEMBL7805212 0.69 TDP1 (0.44) TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1385833-A1 TRIAZINYL AMIDE DERIVATIVES AS ANGIOGENESIS INHIBITORS Amgen Inc. (US) 2004-02-04 EP disclosed
WO-2002083654-A1 TRIAZINYL AMIDE DERIVATIVES AS ANGIOGENESIS INHIBITORS AMGEN INC. (US) 2002-10-24 WO disclosed